Notice 2 Apr 2025 compliance, healthcare, ohio, dea, legal, medical licensing

⚖️DEA Revocation of Registration for Dr. Lager-Fermon in Ohio

The Drug Enforcement Administration issued an Order to Show Cause to Dr. Jennifer Marie Lager-Fermon, which proposed revoking her DEA registration due to the indefinite suspension of her Ohio medical license. Consequently, she is no longer authorized to prescribe controlled substances, and the Agency's findings confirmed her default following the lack of a hearing request.

Learn More
Notice 1 Apr 2025 compliance, healthcare, ohio, registration, dea, drug enforcement, medical licensing

⚖️DEA Revocation Order Impacts Healthcare Business Compliance

The Drug Enforcement Administration (DEA) issued an Order to Show Cause proposing to revoke the registration of Mary Massullo, D.O. due to her lack of authority to handle controlled substances in Ohio, following the permanent revocation of her medical license. The decision emphasizes the importance of compliance with state regulations for medical practitioners and organizations involved in controlled substance handling.

Learn More
Notice 20 Mar 2025 regulatory compliance, medical licensing, drug enforcement administration, mississippi, controlled substances

⚖️DEA Revokes Registration of Hazem Barmada, M.D. for Compliance Issues

The Drug Enforcement Administration has revoked Hazem Barmada, M.D.'s certification due to his lack of licensure in Mississippi, impacting his ability to handle controlled substances. This decision underscores the necessity for medical practitioners to maintain state compliance to retain DEA registrations and operate legally.

Learn More
Notice 20 Mar 2025 california, healthcare compliance, medical licensing, dea, controlled substances

🚫DEA Revokes Registration for Doctor

The Drug Enforcement Administration (DEA) revoked the registration of Dr. Margaret Sprague, citing her lack of authority to prescribe controlled substances following the revocation of her California medical license. This decision emphasizes the critical link between state licensing and federal drug prescriptions, fundamentally impacting practitioners and healthcare businesses operating in compliance with federal regulations.

Learn More